Law360, New York (March 10, 2008) -- Indian generics drugmaker USV has reportedly received a U.S. patent related to the pharmaceutical ingredient used in the blockbuster Alzheimer's drug Aricept, reversing an earlier refusal.
Mumbai-based USV Ltd. filed a patent in 2004 for a process of deriving donepezil hydrochloride, the active ingredient in Aricept, from donepezil oxalate....
